Urticaria and Angioedema in a Patient Diagnosed with COVID-19: Case Report

Basit Öğe Kaydı
dc.authoridAKKUS, ILKNUR/0000-0002-0581-2548
dc.contributor.authorAkkus, Ilknur
dc.contributor.authorKaygusuz, Sedat
dc.date.accessioned2025-01-21T16:34:41Z
dc.date.available2025-01-21T16:34:41Z
dc.date.issued2021
dc.departmentKırıkkale Üniversitesi
dc.description.abstractCoronavirus disease 2019 (COVID-19) disease caused by the Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) virus, which has affected the whole world, can cause clinical pictures ranging from mild cold symptoms to severe lower respiratory tract infections that can cause mortality. Recently, reports of dermatological findings associated with COVID-19 such as urticaria has been increasing. Here, a COVID-19 case presenting with urticaria and angioedema is described. A 26-year-old female patient, who was found to be SARS-CoV-2 positive by polymerase chain reaction performed for being in contact, presented to our outpatient clinic with complaints of itchy, erythematous lesions on her body and swelling in the eyes and throat for four days. The patient received favipiravir treatment for 5 days and these complaints started 4 days after the treatment ended. History of food and other drug allergies, insect bites and chemicals were questioned in the differential diagnosis for etiology, however, no relationship was detected. Systemic corticosteroid and antihistamine treatment was initiated, and edema in the eyes completely regressed and urticaria plaques faded on the 3rd day of the treatment. Dermatological findings may occur simultaneously with the classic symptoms of the disease or before or after symptoms. Although the pathogenesis between dermatological findings and COVID-19 has not been fully elucidated, studies have suggested that viral infections and SARS-CoV-2 can be an etiological agent for chronic or acute urticaria. It is thought that some rashes may be causally related to the viral effect and others to the immune response. It is emphasized that there may be atypical findings such as urticaria/angioedema in order to diagnose COVID-19 disease early and prevent its spread and should be considered in differential diagnosis.
dc.identifier.doi10.5578/flora.20219812
dc.identifier.endpage333
dc.identifier.issn1300-932X
dc.identifier.issue2
dc.identifier.startpage328
dc.identifier.trdizinid521071
dc.identifier.urihttps://doi.org/10.5578/flora.20219812
dc.identifier.urihttps://search.trdizin.gov.tr/tr/yayin/detay521071
dc.identifier.urihttps://hdl.handle.net/20.500.12587/24001
dc.identifier.volume26
dc.identifier.wosWOS:000715129900013
dc.identifier.wosqualityN/A
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakTR-Dizin
dc.language.isoen
dc.publisherBilimsel Tip Yayinevi
dc.relation.ispartofFlora Infeksiyon Hastaliklari Ve Klinik Mikrobiyoloji Dergisi
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/openAccess
dc.snmzKA_20241229
dc.subjectCOVID-19; Urticaria; Angioedema
dc.titleUrticaria and Angioedema in a Patient Diagnosed with COVID-19: Case Report
dc.typeArticle

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
[ X ]
İsim:
Tam Metin/Full Text
Boyut:
724.3 KB
Biçim:
Adobe Portable Document Format
İndir

Koleksiyon

WOS İndeksli Yayınlar Koleksiyonu
Makale Koleksiyonu
TR-Dizin İndeksli Yayınlar Koleksiyonu